Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

F10

F10

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Recombinant rat myeloma cell NS0-F10 and application thereof
Applicant: INST BIOPHYSICS CN ACAD SCIPriority: 2010
CN
COAGULATION FACTOR X (F10) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
Applicant: ALNYLAM PHARMACEUTICALS INCPriority: 2023
US
Use of anti-IsaA F10 antibodies to prevent and ameliorate atopic dermatitis
Applicant: HAWU BIOTECHNOLOGY CO LTDPriority: 2021
CN
针对新冠病毒SARS-CoV-2的单克隆抗体F10
Applicant: 山东宽和正生物医药有限公司Priority: 2020
CN
Pharmaceutical composition capable for the incorporation Febuxostat in the crystalline modifications F10, II, G and A
Applicant: BLUEPHARMA IND FARMACÊUTICA S APriority: 2014
EP
一种靶向GPC3的鲨鱼单域抗体VNAR-F10及其应用
Applicant: 中国海洋大学Priority: 2024
CN
Use of safflower polysaccharide in preparing medicine for treating melanoma diseases
Applicant: YUEYANG HOSPITAL OF INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE SHANGHAI UNIV OF TRADITIONALPriority: 2020
CN
Target spot for virtually screening anti-monkey pox virus medicine and application of target spot
Applicant: UNIV SHANXI MEDICALPriority: 2024
CN